Bristol Myers Squibb Selects ZS To Support Global Commercialization and Analytics Capabilities

Rhea-AI Summary

Bristol Myers Squibb (BMY) has expanded its partnership with ZS, a professional services firm, to enhance its worldwide commercial analytics capabilities. This agreement builds on a successful collaboration initiated in 2015, focusing on BMS’s Business Insights & Analytics group. The partnership aims to utilize data science, marketing mix strategies, forecasting, and brand analytics across over 65 markets. ZS, with over 35 years of experience, is committed to helping BMS drive impactful decision-making to improve patient outcomes.

Positive

• Expansion of partnership with ZS enhances BMS's analytics capabilities.
• Focus on data-driven decision-making may lead to improved patient outcomes.
• Collaboration spans over 65 markets, increasing global reach.

Negative

• None.

EVANSTON, Ill.--(BUSINESS WIRE)-- Global professional services firm ZS has been selected by leading biopharmaceutical company Bristol Myers Squibb (BMS) (NYSE: BMY) to support its worldwide commercial analytics organization. This agreement builds on and expands the existing, successful partnership that BMS and ZS created in 2015.

“We look forward to continuing to serve BMS. It is an honor to help one of the most innovative biopharmaceutical companies in the world transform its analytics capabilities and drive business impact.” said Jaideep Bajaj, chairman of ZS.

The work will support BMS’s Business Insights & Analytics (BIA) group—a global, centralized organization that helps drive business success for all markets and business units across BMS through the appropriate use of data. The scope encompasses areas such as data science, marketing mix, forecasting, business development and brand analytics for more than 65 markets.

“For more than 30 years, BMS and ZS have worked together to solve business challenges and deliver organization-wide impact,” said Rohan Fernando, ZS’s client service lead for BMS. “We are thrilled to continue that partnership and help BMS innovate and drive fact-based decision-making that ultimately helps improve patient outcomes.”

About ZS

ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 35 years of experience and 10,000-plus ZSers in more than 25 offices worldwide, we are passionately committed to helping companies and their customers thrive. To learn more, visit www.zs.com or follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220105005033/en/

Quintin Maidment

The Bliss Group

ZS@TheBlissGrp.com

Source: ZS

FAQ

What is the recent partnership between Bristol Myers Squibb and ZS?

Bristol Myers Squibb has expanded its partnership with ZS to enhance its global commercial analytics capabilities.

When did Bristol Myers Squibb start working with ZS?

Bristol Myers Squibb began its partnership with ZS in 2015.

What will the partnership focus on for Bristol Myers Squibb?

The partnership will focus on data science, marketing mix, forecasting, and brand analytics.

How many markets does the partnership cover?

The partnership will cover over 65 markets globally.

What is the goal of the Bristol Myers Squibb and ZS partnership?

The goal is to drive impactful decision-making and improve patient outcomes through enhanced analytics.